Bakheit A M, Behan P O, Dinan T G, Gray C E, O'Keane V
University of Glasgow.
BMJ. 1992 Apr 18;304(6833):1010-2. doi: 10.1136/bmj.304.6833.1010.
To study the dynamic function of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.
Prospective comparison of patients with postviral fatigue syndrome with two control groups.
Department of neurology, University of Glasgow, Southern General Hospital; department of psychiatry, St James's Hospital, Dublin.
15 patients with postviral fatigue syndrome, 13 age and sex matched healthy subjects, and 13 patients with primary depression.
Serum prolactin concentrations before and one, two, and three hours after administration of buspirone.
Because of the effects of sex hormones on prolactin secretion data for men and women were analysed separately. There was no significant difference in baseline prolactin concentrations between patients with postviral fatigue syndrome and healthy subjects or those with primary depression. However, the percentage difference between peak and baseline values was significantly higher in patients with postviral fatigue syndrome than the control groups (one way analysis of variance: women, p = 0.003; men, p = 0.004).
The results suggest upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome but not in those with primary depression. The buspirone challenge test may therefore be useful in distinguishing these two conditions. Larger studies are required to explore the potential value of drugs acting on central 5-hydroxytryptamine receptors in the treatment of patients with the postviral fatigue syndrome.
研究病毒性疲劳综合征患者下丘脑5-羟色胺受体的动态功能。
对病毒性疲劳综合征患者与两个对照组进行前瞻性比较。
格拉斯哥大学南方总医院神经内科;都柏林圣詹姆斯医院精神科。
15例病毒性疲劳综合征患者、13例年龄和性别匹配的健康受试者以及13例原发性抑郁症患者。
服用丁螺环酮前及服用后1小时、2小时和3小时的血清催乳素浓度。
由于性激素对催乳素分泌有影响,因此对男性和女性的数据分别进行分析。病毒性疲劳综合征患者与健康受试者或原发性抑郁症患者的催乳素基线浓度无显著差异。然而,病毒性疲劳综合征患者峰值与基线值之间的百分比差异显著高于对照组(单因素方差分析:女性,p = 0.003;男性,p = 0.004)。
结果表明病毒性疲劳综合征患者下丘脑5-羟色胺受体上调,而原发性抑郁症患者则不然。因此,丁螺环酮激发试验可能有助于区分这两种情况。需要进行更大规模的研究来探索作用于中枢5-羟色胺受体的药物在治疗病毒性疲劳综合征患者中的潜在价值。